Spire Healthcare Group PLC (LON:SPI)‘s stock had its “add” rating restated by equities researchers at Numis Securities Ltd in a report issued on Thursday. They currently have a GBX 350 ($4.52) price target on the stock. Numis Securities Ltd’s price target suggests a potential upside of 34.51% from the company’s previous close.

Several other brokerages have also commented on SPI. Liberum Capital lowered Spire Healthcare Group PLC to a “hold” rating and decreased their price objective for the company from GBX 400 ($5.17) to GBX 370 ($4.78) in a report on Wednesday, July 19th. Credit Suisse Group reiterated an “underperform” rating on shares of Spire Healthcare Group PLC in a report on Friday, July 21st. Jefferies Group LLC increased their price objective on Spire Healthcare Group PLC from GBX 305 ($3.94) to GBX 350 ($4.52) and gave the company a “hold” rating in a report on Thursday, June 1st. Finally, Berenberg Bank increased their price objective on Spire Healthcare Group PLC from GBX 360 ($4.65) to GBX 390 ($5.04) and gave the company a “buy” rating in a report on Wednesday, June 21st. One analyst has rated the stock with a sell rating, five have given a hold rating and one has issued a buy rating to the stock. Spire Healthcare Group PLC presently has a consensus rating of “Hold” and an average price target of GBX 347 ($4.48).

Spire Healthcare Group PLC (LON SPI) traded up 3.17% on Thursday, hitting GBX 260.20. The stock had a trading volume of 3,350,487 shares. The stock’s 50-day moving average is GBX 327.79 and its 200 day moving average is GBX 332.90. The firm’s market capitalization is GBX 1.04 billion. Spire Healthcare Group PLC has a 1-year low of GBX 228.48 and a 1-year high of GBX 411.00.

Spire Healthcare Group PLC (LON:SPI) last posted its earnings results on Thursday, September 14th. The company reported GBX 8.70 ($0.11) earnings per share for the quarter, topping analysts’ consensus estimates of GBX 8.60 ($0.11) by GBX 0.10 ($0.00). The company had revenue of £481 million during the quarter. Spire Healthcare Group PLC had a return on equity of 3.47% and a net margin of 3.92%. On average, equities research analysts predict that Spire Healthcare Group PLC will post $18.48 earnings per share for the current fiscal year.

WARNING: This story was first posted by American Banking News and is the property of of American Banking News. If you are accessing this story on another publication, it was copied illegally and reposted in violation of international copyright laws. The legal version of this story can be viewed at https://www.americanbankingnews.com/2017/09/16/numis-securities-ltd-reaffirms-add-rating-for-spire-healthcare-group-plc-spi.html.

Spire Healthcare Group PLC Company Profile

Spire Healthcare Group plc is a United Kingdom-based independent hospital group. The Company provides in-patient, daycase and out-patient care from approximately 40 hospitals, 10 clinics and over two specialist care centers across the United Kingdom. The Company also owns and operates a sports medicine, physiotherapy and rehabilitation brand, Perform, and a screening service, Lifescan, as well as national pathology services.

Analyst Recommendations for Spire Healthcare Group PLC (LON:SPI)

Receive News & Ratings for Spire Healthcare Group PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Spire Healthcare Group PLC and related companies with MarketBeat.com's FREE daily email newsletter.